Dr. Christopher G. Cumming, DMD, PHD, FDSRCS Dentist Medicare: Not Enrolled in Medicare Practice Location: 324 E 2nd St, Moundridge, KS 67107 Phone: 620-345-2100 Fax: 620-273-8931 |
News Archive
Aeterna Zentaris Inc. today announced that it continues to expect to file a New Drug Application (NDA) early next year, for its oral ghrelin agonist, AEZS-130, as a diagnostic test for adult growth hormone deficiency (AGHD), after receiving notification from the United States Food and Drug Administration (FDA) that Fast Track designation had not been granted.
The Dallas Morning News reports that rural health providers "are keeping a wary eye on proposed health care changes under debate in Congress. ... Democrats and Republicans from rural areas in the South and Midwest succeeded in getting some relief for the rural health care system written into the Senate and House bills under debate.
Precision cancer medicine - diagnosis and treatment based on the genetic abnormalities of a specific tumor - is playing an ever-larger role in cancer care. The field got a boost earlier this year when President Barack Obama proposed a $215 million federal Precision Medicine Initiative with cancer as one of its priorities.
Nepal can greatly reduce its vulnerability to climate-sensitive infectious diseases by improving its public health surveillance and prediction capabilities, says a paper due to be published April in Acta Tropica.
Scientists have discovered gene expression differences that could lead to better ways to classify, predict outcome, and treat juvenile idiopathic arthritis (JIA). Eventually such findings could enable doctors to target more aggressive treatment to children at risk of more severe arthritis, while those likely to have milder disease could be spared the stronger treatments that carry a greater risk of side effects. The researchers were supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health.
› Verified 7 days ago